Home  /  CICM Fellowship  /  Study notes  /  Rhabdomyolysis and Crush Syndrome: Pathophysiology, Diagnosis and Management

Rhabdomyolysis and Crush Syndrome: Pathophysiology, Diagnosis and Management

CICM Fellowship LO CICMF_TRAUMA_6 2,071 words
Free preview. This study note maps to learning objective CICMF_TRAUMA_6 in the CICM Fellowship curriculum. Inside Primex you get the full set of CICM Fellowship notes, AI-graded SAQs and written-paper practice, voice viva with an AI examiner, exam-style MCQs, and a curriculum tracker that ticks off every learning objective as you go. For exam format, timeline and failure-mode commentary, see the CICM Fellowship 2026 Study Guide.

Overview and Clinical Context

Rhabdomyolysis is the breakdown of skeletal muscle with release of intracellular contents into the systemic circulation. In the ICU, it ranges from an incidental biochemical finding to a life-threatening syndrome with multi-organ failure. The intensivist must understand the underlying mechanisms deeply enough to anticipate complications, individualise fluid targets, and make timely decisions about renal replacement therapy. In mass casualty settings, crush syndrome - the systemic manifestation of widespread rhabdomyolysis following compressive injury - demands a different operational mindset: triage, resource allocation, and pre-hospital intervention become paramount.


Pathophysiology

Cellular Mechanisms of Muscle Injury

The common final pathway is failure of the $Na^+/K^+$-ATPase pump, leading to intracellular $Na^+$ and $Ca^{2+}$ accumulation. This can result from:

Elevated intracellular $Ca^{2+}$ activates phospholipases, proteases, and endonucleases, driving irreversible cellular destruction. Cell contents - myoglobin, creatine kinase (CK), potassium, phosphate, urate, lactate dehydrogenase (LDH), and myocyte enzymes - flood the interstitium and then the vascular compartment.

Renal Injury Mechanisms

Acute kidney injury (AKI) is the most feared complication, occurring in 15-50% of rhabdomyolysis cases. Three mechanisms operate simultaneously:

Mechanism Detail
Tubular obstruction Myoglobin precipitates with Tamm-Horsfall protein in acidic urine, forming casts
Direct tubular toxicity Myoglobin undergoes oxidative cycling producing free radicals; ferrihaemate damages proximal tubular cells
Renal vasoconstriction Myoglobin scavenges nitric oxide → afferent arteriolar constriction; hypovolaemia compounds this

Aciduria (pH < 5.6) dramatically worsens myoglobin cast precipitation, providing the physiological rationale for urinary alkalinisation.

Systemic Complications

Massive third-space fluid shifts into injured muscle and capillary leak cause profound hypovolaemia. Compartment syndrome can both cause and result from rhabdomyolysis, creating a vicious cycle. Systemic release of muscle contents drives:


Diagnosis

Clinical Features

Presentation varies from asymptomatic CK elevation detected on routine bloods to the classic triad of muscle pain, weakness, and dark ("coca-cola" or "tea-coloured") urine. In sedated ICU patients, diagnosis is often biochemical.

High-risk presentations to actively screen: - Trauma with prolonged immobilisation or crush - Polytrauma, especially after extrication - Severe burns - Status epilepticus or prolonged seizures - Stimulant toxicity (cocaine, amphetamines, MDMA) - Malignant hyperthermia or NMS - Statin use combined with CYP3A4 inhibitors

Biochemical Diagnosis

Investigation Significance Threshold / Finding
CK Most sensitive marker >1000 U/L diagnostic; >5000 U/L severe; >15,000-20,000 U/L high risk for AKI
Myoglobin (urine) Appears before tea-coloured urine Detected at myoglobin >250 mcg/L urine
Myoglobin (serum) Peaks earlier than CK; clears rapidly >1500 mcg/L significant
Urinalysis Dipstick positive for blood with no RBCs on microscopy Myoglobinuria signature
Creatinine / urea Rising indicates AKI Rate of rise, not absolute value
Potassium Life-threatening elevation >6.0 mmol/L requires urgent management
Phosphate Often markedly elevated Contributes to hypocalcaemia
Calcium Initially low (complexing with phosphate) Later elevated (recovery phase)
Uric acid Elevated from purine release Contributes to tubular obstruction
Urine pH Critical for management Target >6.5 with alkalinisation strategy
LFTs Elevated AST and ALT from muscle (not liver) Can confuse hepatic assessment

CK peaks at 24-72 hours then falls with a half-life of approximately 36 hours. A rising CK beyond 72 hours suggests ongoing muscle injury (e.g., ongoing compartment syndrome, evolving myopathy).

Monitoring

Serial 4-6 hourly CK, electrolytes, renal function, and urine output in the acute phase. Urine pH measurement guides alkalinisation strategy. Continuous cardiac monitoring is mandatory given hyperkalaemia risk. Compartment pressure measurement (threshold >30 mmHg, or within 30 mmHg of diastolic pressure) if clinical concern.


Management

Fluid Resuscitation - The Cornerstone

Aggressive early volume replacement is the single most important intervention to prevent AKI. Goals are to restore renal perfusion and maintain tubular flow to flush myoglobin casts.

Targets: - Urine output: 200-300 mL/hr in the acute phase (or 3-5 mL/kg/hr) - This is significantly higher than standard resuscitation targets and requires careful monitoring - Titrate to urine output rather than CVP or MAP alone - Crystalloid preferred: isotonic saline (0.9% NaCl) or Hartmann's/Ringer's lactate; avoid hypotonic solutions

Fluid volume: Can be enormous - 6-12 litres in first 24 hours not unusual in severe crush; up to 1.5 litres/hour may be required initially.

Caution: Overzealous fluid in compartment syndrome worsens oedema and may increase compartment pressure. Once urine output target achieved, titrate down. Monitor for pulmonary oedema, especially in elderly or those with cardiac impairment.

Urinary Alkalinisation

Rationale

Alkalinisation increases urine pH above 6.5, which: 1. Reduces precipitation of myoglobin with Tamm-Horsfall protein (precipitation dramatically increases at pH <5.6) 2. Reduces conversion of myoglobin to the more nephrotoxic ferrihaemate form (favoured in acidic environment) 3. Reduces uric acid cast formation 4. May mitigate vasoconstriction (modest systemic alkalosis improves renal perfusion)

Method

Limitations and Contraindications

Forced Diuresis with Loop Diuretics

Mannitol (0.25-0.5 g/kg IV) has been used as an osmotic diuretic to increase tubular flow and as a free radical scavenger. It can also reduce compartment pressure (osmotic gradient). However: - Avoid in oliguria (risk of volume overload and osmolar gap toxicity) - No robust evidence of superiority over saline alone - Mannitol is largely falling out of favour as first-line

Frusemide may help maintain urine output in established AKI, but forced diuresis is not beneficial and carries risks of volume depletion if used without adequate resuscitation. It may acidify urine, which is counterproductive in the alkalinisation strategy. Do not use frusemide as primary prevention of myoglobin-induced AKI.

Management of Hyperkalaemia

This is the primary life-threatening emergency in crush syndrome and must be managed in parallel with fluid resuscitation.

Intervention Mechanism Dose / Details
Calcium gluconate (or chloride) Membrane stabilisation 10 mL of 10% calcium gluconate IV over 5-10 min; repeat if ECG changes persist
Insulin + glucose $K^+$ shift intracellular 10 units actrapid + 50 mL 50% dextrose IV
Nebulised salbutamol $\beta_2$-mediated $K^+$ uptake 10-20 mg nebulised
Sodium bicarbonate Intracellular shift (modest, mainly with concurrent acidosis) 50-100 mmol IV
Sodium zirconium cyclosilicate or patiromer Gut cation exchanger Oral/enteral; for non-emergency ongoing management
Resonium (calcium or sodium polystyrene) Gut binding Slow onset, less favoured in acute setting
Haemodialysis / CRRT Definitive removal When refractory or AKI established

Haemodialysis for Refractory Hyperkalaemia

Indications for RRT in rhabdomyolysis:

Indication Threshold
Refractory hyperkalaemia K+ >6.5 mmol/L unresponsive to medical therapy, or ECG changes
Oliguria/anuria despite resuscitation <0.5 mL/kg/hr for >6-12 hours
Fluid overload with AKI Pulmonary oedema
Severe metabolic acidosis pH <7.1 unresponsive to bicarbonate
Uraemia Uraemic complications

Intermittent haemodialysis is highly effective for acute hyperkalaemia in established AKI - potassium clearance is rapid (can reduce K+ by 1 mmol/L/hour). CRRT is preferred when haemodynamic instability limits intermittent HD, or in mass casualty settings where prolonged continuous electrolyte control is needed. Note: myoglobin itself (MW ~17,000 Da) is poorly removed by standard HD membranes; high-flux or high-cutoff membranes can achieve limited myoglobin clearance but clinical benefit is unproven.

Compartment Syndrome

Urgent surgical fasciotomy is required when: - Compartment pressure >30 mmHg, OR - Within 30 mmHg of diastolic BP ($\Delta P = P_{diastolic} - P_{compartment} < 30$ mmHg) - Clinical signs: pain out of proportion, paraesthesia, pallor, pulselessness, paralysis

Post-fasciotomy wounds create significant ongoing fluid and electrolyte management challenges - massive evaporative losses and ongoing third-spacing.


Crush Syndrome in Mass Casualty Incidents

Definition and Specific Pathophysiology

Crush syndrome is the systemic manifestation of rhabdomyolysis following prolonged compressive injury (typically >1 hour). The key danger is the reperfusion phase after extrication - compressive forces are released and a large bolus of myoglobin, potassium, and acid enters the circulation simultaneously. Cardiac arrest can occur within minutes of extrication.

Pre-Hospital Priorities

Triage Considerations

In mass casualty incidents with multiple crush victims:

Triage Category Criterion
Immediate (P1) Haemodynamically unstable, viable, salvageable
Delayed (P2) Haemodynamically stable, ambulatory or limited injuries
Expectant (P3) >6 hour entrapment + unresponsive + bilateral lower limb crush in resource-scarce setting
Deceased (P4) Obvious non-survivable injuries

Resource scarcity fundamentally alters decision-making - dialysis capacity becomes a critical bottleneck. A single crush victim with AKI may require 12-24 hours/day of RRT; 50 victims overwhelm any health system.

Hospital-Level Mass Casualty Response


CICM Final Implications

Hot Case / Viva Approach

When presented with a patient with rhabdomyolysis in the ICU:

  1. Establish aetiology - trauma, toxin, metabolic, iatrogenic (prolonged immobility, statin + drug interaction)
  2. Quantify severity - CK level, trend, urine colour, degree of AKI
  3. Immediate threats - hyperkalaemia (ECG), compartment syndrome
  4. Fluid strategy - articulate your urine output target (200-300 mL/hr) and how you will achieve it; be explicit about monitoring strategy
  5. Alkalinisation - know the rationale, the method, the targets (urine pH >6.5), and the limitations (worsening hypocalcaemia, futile in anuria)
  6. RRT indications - do not wait for severe uraemia; refractory hyperkalaemia is the primary indication; justify modality choice (IHD for rapid K+ correction vs CRRT for haemodynamic instability)
  7. Compartment syndrome - maintain a low threshold; serial clinical examination in sedated patients

Anticipated Viva Questions

Key Numbers to Know

Parameter Value
CK threshold for AKI risk >5000 U/L (significant), >15,000-20,000 U/L (high risk)
Urine output target 200-300 mL/hr (3-5 mL/kg/hr)
Urine pH target with alkalinisation >6.5
Fasciotomy threshold (absolute) Compartment pressure >30 mmHg
Fasciotomy threshold ($\Delta P$) Diastolic BP − compartment pressure <30 mmHg
Naloxone initial dose (opioid reversal, incidental) 0.4-2 mg IV/IM/SC
Pralidoxime for OP poisoning (if rhabdomyolysis context) 1 g IV then 250-400 mg/hr infusion
Primex

Practice this topic in the app

Work through MCQs on this exact LO, run written or viva practice mapped to CICMF_TRAUMA_6, or ask PRIMEX a clinical question framed for CICM Fellowship. Your free trial covers all 20 specialist exams.

Start 7-day free trial
Start free trial